Sanofi-Aventis Wins Canadian Ruling In Generic Plavix Case

Sanofi-Aventis said it has won in an appeal by Canadian generic drugmaker Apotex which is prohibited from selling cheaper copies of Sanofi's bloodthinner Plavix in Canada.

French drugmaker Sanofi-Aventis and U.S. partner Bristol-Myers Squibbsaid in a statement the court had dismissed an appeal by Apotex to sell a generic version of Plavix, a blockbuster drug that Bristol-Myers sells for Sanofi in the United States.